GSK (GSK) and the University of Oxford announced that they have entered a new research collaboration focused on the potential of cancer ...

GSK (GSK) announced that the European Medicines Agency, EMA, has accepted for review the regulatory application of a prefilled syringe ...

The Goldsmiths' Company has unveiled a striking new visual identity, updating its rich heritage for a fresh contemporary ...

GSK will invest up to £50 million in the new project, which could inform future development of cancer vaccines.

Kirkland, Latham, Paul Weiss and others have replaced the likes of Sullivan & Cromwell, Clifford Chance and Slaughter and May ...

Stocks Sink as Investors Worry About China’s A.I. Advances A jolt of panic hit technology stocks on Monday, with investors rattled by fears that A.I. advances by Chinese upstarts could threaten ...

Through a flurry of orders, the new president quickly began driving the country in a different direction on many contentious issues. The 14th Amendment overturned the 1857 decision that denied ...

The new visual identity aims to convey the spirit of the Goldsmith’s Company and its craft and trade, drawing on iconic ...

Inovio Pharmaceuticals Inc.-4.80% $82.67M ...

GlaxoSmithKline Pharmaceuticals Ltd. key Products/Revenue Segments include Pharmaceuticals, Service Income and Other Operating Revenue for the year ending 31-Mar-2024.For the quarter ended 30-09-2024, ...